Search Results for: can-fite

From psoriasis to Covid-19

One of the treatments being developed by Israel’s Can-Fite (see here) is CF-101 (Piclidenoson) which is in Phase 2 & 3 trials for psoriasis, rheumatoid arthritis and other diseases.  Can-Fite is shortly to commence a Phase 2 trial of CF-101 … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Liver cancer treatment available

I reported previously (see here) on the Namodenoson (CF102) liver cancer treatment from Israel’s Can-Fite. After Phase 2 testing, a supply of CF102 has been manufactured for “compassionate use” on critically ill patients at Rabin Medical Center in Petah Tikva. … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Agreement for psoriasis treatment

I reported previously (see here) on the small molecule treatments from Israel’s Can-Fite for psoriasis, liver and inflammatory diseases, and cancer. Can-Fite AND South Korea-based Kyongbo have just signed a distribution agreement for Can-Fite’s psoriasis treatment Piclidenoson (CF101). https://www.calcalistech.com/ctech/articles/0,7340,L-3767633,00.html

Posted in Israel's Medical Achievements | Leave a comment

Combatting fatty liver disease

In advance of Phase 2 trials, preclinical data showed the potential efficacy of Namodenoson (CF102) from Israel’s Can-Fite (see Jan 2012).  It inhibited the growth and proliferation of liver fibrosis cells, supporting its potential ability to combat non-alcoholic fatty liver … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Success in treating rheumatoid arthritis

Israel’s Can-Fite BioPharma has announced positive results in its Phase IIb trial of their CF101 treatment for patients with active rheumatoid arthritis. http://www.globes.co.il/serveen/globes/docview.asp?did=1000903835&fid=1725

Posted in Israel's Medical Achievements | Leave a comment

Another Israeli wonder treatment?

During trials by Israel’s Can-Fite BioPharma of its anti-inflammatory CF101 medication, the company discovered that the active ingredient is suitable for treating impotence. Can-Fite only found this out when they noticed that patients were not returning all the drugs at … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Good news for psoriasis patients

Israel’s Can-Fite BioPharma announced positive interim results of its Phase II/III clinical trial of CF101 for the treatment of psoriasis, and is continuing to enrol patients in the study. http://www.globes.co.il/serveen/globes/docview.asp?did=1000788461&fid=1725

Posted in Israel's Medical Achievements | Leave a comment

Israeli drug can save sight

Israel’s Can-Fite BioPharma has reported successful pre-clinical trials of CF101 for the treatment of anterior uveitis – the inflammation of the iris. An earlier trial found CF101 effective in treating posterior uveitis – inflammation of the retina. Uveitis is a … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Israeli liver cancer drug success

Israel’s Can-Fite BioPharma has reported success in the Phase I/II clinical trial of its CF102 drug for the treatment of liver cancer (hepatocellular carcinoma or HCC). It was also successful in Phase I/II trials for treating Hepatitis C. http://www.globes.co.il/serveen/globes/docview.asp?did=1000712199&fid=1725

Posted in Israel's Medical Achievements | Leave a comment